ALB vs DD
Albemarle and DuPont, side by side.
Prices and company dataas of yesterday's close
- ALBBuy moresales growth, past year24%
Albemarle's sales grew 24% over the past year, and it pays a 1.6% dividend that it has raised for 31 years in a row.
- DDKeepin the past month+20%
DuPont rose 20% over the past month, far more than other chemical makers (up 9.1%), and its sales grew 95% over the past year.
Percent return
- ALB−6.56%
- DD+30.65%
Nov 11, 2025 to Nov 11, 2026
Where they differ
- Company size: ALB $14.0B, DD $18.6B.
- Sales growth, 1 yr: ALB +24%, DD +95%. DD is ahead.
- Price for $1 of next year's profit: ALB $9, DD $18. ALB is ahead.
- Profit per $1 of sales: ALB 17¢, DD 14¢. ALB is ahead.
- Cash minus debt: ALB −$152M, DD −$1.53B. ALB is ahead.
- Price change, 1 yr: ALB −6.6%, DD +31%. DD is ahead. S&P 500 +12%.
- How much the price swings: ALB 41%, DD 28%. DD is ahead.
| Measure | ALBAlbemarle | DDDuPont |
|---|---|---|
| Price and returns | ||
| Price | $95.95 | $155.62 |
| Today | Best in this row: +1.07% | −0.80% |
| 1 month | −5.23% | Best in this row: +19.70% |
| 3 months | −25.58% | Best in this row: +8.18% |
| This year | −31.58% | Best in this row: +30.63% |
| 1 year | −6.56% | Best in this row: +30.65% |
| 5 years | −62.54% | Best in this row: +68.59% |
| From 52-week high | −55.2% | −0.8% |
| How much it swings (90 days) | 41% | Best in this row: 28% |
| Valuation | ||
| Market value | $14.0B | $18.6B |
| Price vs last year's earnings | Best in this row: 25.9× | 121.1× |
| Price vs next year's expected earnings | Best in this row: 9.1× | 18.3× |
| Price vs earnings, adjusted for growth | – | 0.89× |
| Price to sales | Best in this row: 1.9× | 2.8× |
| Price vs cash it brings in | Best in this row: 8.1× | 30.9× |
| Company value vs operating profit | Best in this row: 7.0× | 12.8× |
| Growth | ||
| Revenue growth, 1 year | +24.4% | Best in this row: +95.5% |
| Revenue growth a year, last 3 years | Best in this row: −11.1% | −19.3% |
| Earnings per share growth, last year | Best in this row: +69.4% | +63.5% |
| Earnings per share growth expected next year | −23.9% | Best in this row: +9.8% |
| Profitability | ||
| Kept from sales after making the product | 26.2% | Best in this row: 35.5% |
| Kept as operating profit | Best in this row: 17.1% | 14.4% |
| Kept as final profit | Best in this row: 8.4% | 4.3% |
| Kept as spare cash | Best in this row: 23.5% | 8.9% |
| Profit on shareholders' money | Best in this row: 7.0% | 2.2% |
| Profit on all money put in | Best in this row: 6.9% | 4.1% |
| Balance sheet | ||
| Net cash (cash minus debt) | Best in this row: −$152M | −$1.53B |
| Debt for each $1 of shareholders' money | Best in this row: 0.18× | 0.23× |
| Short-term assets per $1 of bills due | 2.34× | Best in this row: 2.36× |
| Dividend yield | Best in this row: 1.65% | 1.64% |
| Share of profit paid as dividends | Best in this row: 38% | 109% |
| Our readPro | ||
| Our call | Buy more | Keep |
| Why | Albemarle's sales grew 24% over the past year, and it pays a 1.6% dividend that it has raised for 31 years in a row. | DuPont rose 20% over the past month, far more than other chemical makers (up 9.1%), and its sales grew 95% over the past year. |
| Where the price sits | in the full report | in the full report |
| Our overall score (out of 100) | 60 | Best in this row: 62 |
| Our value score | Best in this row: 65 | 53 |
| Our growth score | 65 | Best in this row: 67 |
| Our quality score | 45 | Best in this row: 56 |
| Our price trend score | 61 | Best in this row: 67 |
| Earnings and analysts | ||
| Analyst consensus | Buy | Buy |
| To average analyst target | Best in this row: +55.4% | +8.3% |
| Average analyst target | $149.07 | $168.50 |
| Analysts rating it a buy | 61% | Best in this row: 78% |
| Buy ratings added, 3 months | +1 | +1 |
| Analysts covering | 14 | 12 |
Too close to call
No clear pick between these two
DDSales growth +95.5% vs +24.4%
ALB +24.4%, DD +95.5%.DDForward P/E per point of sales growth 0.19 vs 0.37
ALB 0.37, DD 0.19.ALBOur call: Buy more vs Keep
ALB Buy more, DD Keep.ALB+55.4% to the average analyst target, vs +8.3%
ALB +55.4%, DD +8.3%.Cover this stock to see the full report
The call, its reasons and what would change it are free for everyone. The price zones, the whole brief and how the call has moved come with covering a stock. Use one of your three covered slots, or go Pro for every stock.
Prices as of yesterday, 3:59 PM ET. A view, not advice.